Masahiko MoriyamaPresident & Representative Director This is Moriyama from T&D Holdings. Thank you very much for taking the time out of your busy schedules...
This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As...
Investment thesis LSI Industries (NASDAQ:LYTS) stock has rallied more than 100% over the past twelve months. My valuation analysis suggests the stock is still...
Lockheed Martin Corporation. (NYSE:LMT) Q2 2023 Earnings Conference Call July 18, 2023 11:00 AM ET Company Participants Maria Ricciardone Lee – Vice President of...
By Frederick Fromm, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group While caution in some areas of the commodities space may be prudent, there...
ImmunoGen (NASDAQ:IMGN) is a large biopharmaceutical company (market cap of $4.8 billion) that uses antibody-drug conjugate (‘ADC’) technology to develop novel therapeutics against cancer....
Repligen (NASDAQ:RGEN) offers a comprehensive suite of products, including filtration, chromatography, process analytics, and proteins, catering to both upstream and downstream processes in the...